Pharmacy
News
Drug granted fast track designation for MF
mycosis fungoides The US Food and Drug Administration (FDA) has granted fast track designation to Resimmune® (A-dmDT390-bisFv[UCHT1]) for the...
News
FDA grants drug orphan designation for PNH
The US Food and Drug Administration (FDA) has granted orphan drug designation to Coversin as a treatment for paroxysmal nocturnal hemoglobinuria (...
News
FDA expands approval of blinatumomab
and solution for infusion Photo courtesy of Amgen The US Food and Drug Administration (FDA) has granted accelerated approval for blinatumomab (...
News
FDA approves new indication for ofatumumab in CLL
Photo courtesy of GSK The US Food and Drug Administration (FDA) has approved the use of ofatumumab (Arzerra®) in combination with fludarabine and...
News
NICE approves bosutinib for routine NHS use
The National Institute for Health and Care Excellence (NICE) has issued a final guidance recommending that bosutinib (Bosulif), a tyrosine kinase...
News
FDA grants drug orphan designation for CLL
The US Food and Drug Administration (FDA) has granted orphan drug designation to the PI3K delta inhibitor TGR-1202 for the treatment of chronic...
News
Drug granted breakthrough designation for BPDCN
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for SL-401 in the treatment of blastic plasmacytoid...
News
Drug granted orphan designation for MAS
Image from Flickr The US Food and Drug Administration (FDA) has granted orphan drug designation for dusquetide as a treatment for macrophage...
News
FDA rejects antidote to factor Xa inhibitors
Photo courtesy of Pfizer and Bristol-Myers Squibb The US Food and Drug Administration (FDA) has issued a complete response letter regarding the...
News
Drug no longer in development for DLBCL, other cancers
ProNAi Therapeutics recently announced its decision to stop development of PNT2258, a drug designed to treat cancers characterized by...
News
NICE recommending long-term ticagrelor
Photo from AstraZeneca The National Institute for Health and Care Excellence (NICE) has published a draft guidance recommending the antiplatelet...